Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyslipidaemia.

Paul Durrington1

  • 1University Department of Medicine, Manchester Royal Infirmary, Oxford Road, M13 9WL, Manchester, UK. pdurrington@man.ac.uk >

Lancet (London, England)
|September 6, 2003
PubMed
Summary
This summary is machine-generated.

Lowering serum cholesterol is crucial for preventing heart disease. This review covers the clinical signs and management of lipid disorders, including complex cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis.

Current opinion in lipidology·2024
Same author

Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.

Current opinion in lipidology·2024
Same author

Blood lipids after COVID-19 infection.

The lancet. Diabetes & endocrinology·2023
Same author

Mathematical modelling of the most effective goal of cholesterol-lowering treatment in primary prevention.

BMJ open·2022
Same author

Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.

Atherosclerosis·2020
Same author

Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models.

BMJ open·2020
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Serum cholesterol management is vital for preventing coronary heart disease and atherosclerotic disease.
  • Widespread use of statins necessitates effective population-level strategies for lipid management.
  • Identification and assessment of elevated cholesterol, triglycerides, and low HDL-cholesterol are common clinical needs.

Purpose of the Study:

  • To review the clinical manifestations of disordered lipid metabolism (dyslipidaemia).
  • To discuss the management strategies for various lipid disorders.
  • To address complex or treatment-resistant dyslipidaemias.

Main Methods:

  • Literature review of clinical manifestations of dyslipidaemia.
  • Synthesis of current management guidelines and treatment approaches.

Related Experiment Videos

  • Analysis of challenges in managing complex lipid disorders.

    • Main Results:

    • Dyslipidaemia presents with diverse clinical signs requiring assessment.
    • Many lipid disorders are manageable with standard treatments.
    • Complex or resistant cases necessitate tailored therapeutic strategies.

    Conclusions:

    • Effective management of dyslipidaemia is essential for cardiovascular health.
    • A comprehensive understanding of clinical manifestations aids diagnosis.
    • Personalized treatment plans are key for complex and resistant lipid disorders.